However, accumulating retrospective studies have found that for selective metastatic PCa, local treatment such as RP would improve symptoms, PFS and PSA benefits, and even survival benefits (Rajwa et al., 2023). This evidence concerns the gene KLK3 and posterior cortical atrophy.